Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmX Technologies ( (AU:PHX) ) has shared an announcement.
PharmX Technologies Limited has lodged a new application with the ASX for quotation of additional ordinary fully paid shares under the code PHX. The filing details the registration information and confirms the company is seeking quotation of the newly issued securities in accordance with ASX Listing Rules.
The company is requesting quotation for 59,950,679 ordinary fully paid shares, with an issue date of February 25, 2026. These securities form part of transactions previously flagged to the market, indicating a significant expansion of PharmX’s listed capital base that could influence liquidity and ownership structure for existing shareholders.
More about PharmX Technologies
PharmX Technologies Limited is an Australian-listed company trading under the ASX code PHX. The firm operates within the broader technology and healthcare ecosystem, though the filing primarily identifies it as a listed issuer rather than detailing specific products, services or market segments.
Average Trading Volume: 801,475
Technical Sentiment Signal: Buy
Current Market Cap: A$86.93M
For an in-depth examination of PHX stock, go to TipRanks’ Overview page.